Diagnostic Testing and Climate Change Intersect in New Initiative
Abbott is partnering with the CLIMADE consortium to assess and potentially mitigate the impact climate change has on disease outbreaks.
Read MorePosted by Chris Wolski | Apr 20, 2023 | Disease States, Education |
Abbott is partnering with the CLIMADE consortium to assess and potentially mitigate the impact climate change has on disease outbreaks.
Read MorePosted by Eli Patterson | Apr 20, 2023 | Gastrointestinal Infections, Sponsored |
Childhood diarrhea is a major health concern globally. This UAE case-control study uses a multiplex PCR approach to identify gastrointestinal pathogens in children with diarrhea and their prevalence in asymptomatic children. The study reveals new insights into the causes of childhood diarrhea, with significant implications for global health.
Read MorePosted by Andy Lundin | Apr 17, 2023 | Sequencing Systems |
Metagenomic sequencing offers actionable antimicrobial resistance predictions for bloodstream infections faster than conventional lab tests.
Read MorePosted by Andy Lundin | Mar 9, 2023 | Leukemia |
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read MorePosted by Andy Lundin | Mar 3, 2023 | POC Rapid Assays |
InBios has been granted the U.S. Food and Drug Administration’s (FDA) first marketing rights for an anthrax point-of-care (POC) test.
Read More